Manning & Napier Advisors LLC purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 173,781 shares of the company’s stock, valued at approximately $22,484,000.
Several other institutional investors have also added to or reduced their stakes in the stock. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in Merck KGaA during the second quarter valued at $942,087,000. Bank of Nova Scotia bought a new stake in shares of Merck KGaA in the 2nd quarter worth $281,696,000. Danske Bank A S purchased a new stake in shares of Merck KGaA during the second quarter valued at approximately $276,535,000. Cullen Capital Management LLC bought a new stake in Merck KGaA in the second quarter worth about $259,158,000. Finally, Korea Investment CORP purchased a new stake in Merck KGaA in the 2nd quarter worth about $239,191,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Stock Performance
OTCMKTS:MKGAF opened at $163.45 on Tuesday. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a market cap of $21.12 billion, a price-to-earnings ratio of 24.95 and a beta of 0.96. The business’s fifty day moving average is $162.78 and its 200 day moving average is $148.59.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
